Passage Bio Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Passage Bio Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Passage Bio Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Passage Bio Inc. is PASG:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Passage Bio Inc. has its primary listing on NASDAQ. You can trade Passage Bio Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Passage Bio Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Passage Bio Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Passage Bio Inc..